Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | CA4 | P22748 | 3/20 | 0.55 |
| ▸ | CA7 | P43166 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | PRNP | P04156 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6322701 | 0.90 | CA1 (0.54) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6323533 | 0.90 | ALDH1A1 (0.47) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6316785 | 0.88 | CA1 (0.52) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6317667 | 0.88 | CA2 (0.52) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6318552 | 0.87 | ALDH1A1 (0.50) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6319063 | 0.86 | CA2 (0.51) | CA1CA2CA4CA7KMT2A | |
| SCHEMBL6316598 | 0.85 | CA1 (0.56) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6318170 | 0.84 | ALDH1A1 (0.45) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6316464 | 0.81 | HPGD (0.56) | CA1CA2CA4CA7ALDH1A1 | |
| SCHEMBL6322551 | 0.80 | CA1 (0.54) | CA1CA2CA4CA7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | PFIZER ITALIA S.R.L. (IT) | 2005-03-17 | — | — | US | claimed |
| EP-1435948-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-07-14 | — | — | EP | claimed |
| WO-2003013517-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2003-02-20 | — | — | WO | claimed |
| US-12420503-B2 | Late-stage catalysis of fast room-temperature polymerizations | ESSILOR INTERNATIONAL (FR) | 2025-09-23 | — | — | US | disclosed |
| US-20250108574-A1 | LATE-STAGE CATALYSIS OF FAST ROOM-TEMPERATURE POLYMERIZATIONS | ESSILOR INTERNATIONAL (FR) | 2025-04-03 | — | — | US | disclosed |
| EP-4253019-A1 | LATE-STAGE CATALYSIS OF FAST ROOM-TEMPERATURE POLYMERIZATIONS | Essilor International (FR) | 2023-10-04 | — | — | EP | disclosed |
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | PFIZER ITALIA S.R.L. (IT) | 2005-03-17 | — | — | US | disclosed |
| US-6844415-B1 | Polymerizable compositions for making thio containing resins including a salt catalyst and process for making thio containing | ESSILOR INTERNATIONAL-COMPAGNIE GENERAL D'OPTIQUE (FR) | 2005-01-18 | — | — | US | disclosed |
| EP-1435948-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003013517-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2003-02-20 | — | — | WO | disclosed |
| US-5973098-A | CASTING OPTICAL LENSES | ESSILOR INTERNATIONAL - COMPAGNIE GENERALE D'OPTIQUE (FR) | 1999-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | MAP3K9, MAP3K19, MAP4K2 | CA1 2406/4885CA2 2764/4885CA4 4029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.